… The acquisition of β-lactamases, … infections. During the past decade, significant advances
were made in the development of novel BL-β-lactamase inhibitor (BLI) combinations to target β-…

… Since then, several other β-lactam antibiotics have been introduced in the therapy, … bacterial
infections. Their antibacterial efficacy has been kept in check by the emergence of bacterial …

… that the β-lactams will soon no longer be able to stop deadly bacterial infections. Objective:
… a means to enhance the performance of β-lactam antibiotics against drug-resistant bacteria, …

… , the β-lactams have become some of the most critical and widely-prescribed agents to
counteract bacterial infections … In this review, we provide descriptions of the newest β-lactams that …

… for the treatment of patients with infections caused by Gram-… or β-lactams for the treatment
of Gram-positive infections. 12 … more effective than glycopeptides or β-lactams (odds ratio [OR…

… the data that shed light on how β-lactams interact with myeloid cells during bacterial …
overview of the impact of β-lactams on innate immunity during the treatment of bacterial infections. …

… bacterial infections in both community and hospital settings. In particular, two types of strains
have compromised the clinical utility of currently available antibiotics and underscored the …

… more effective therapeutics to combat bacterial infection and has provided new research …
The concept of using chemicals to alleviate diseases, particularly infectious diseases, dates …

… This aspect of membrane physiology is a key issue in the field of infectious … infectious
diseases that are resistant to multiple antibiotics. Multi-drug resistant (MDR) bacterial infections …

… patients liable to Gram-positive bacterial infections, particularly those due to viridans … β-lactam/β-lactamase
inhibitor combinations hold out promise for preventing nosocomial infections …